MedPath
FDA Approval

Methenamine Hippurate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 23, 2024
Labeling Type
Human Prescription Drug Label

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Aurobindo Pharma Limited

Aurobindo Pharma Limited

650381903

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Methenamine Hippurate

Product Details

NDC Product Code
65862-782
Application Number
ANDA205661
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 23, 2024
Code: M329791L57Class: ACTIBQuantity: 1 g in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TYClass: IACT
© Copyright 2025. All Rights Reserved by MedPath